Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Progenitor Cells Predict Heart Disease Severity

10.03.2004


Duke University Medical Center researchers have uncovered a strong relationship between the severity of heart disease and the level of endothelial progenitor cells circulating in the bloodstream. This relationship, if confirmed by ongoing studies, could represent an important new diagnostic and therapeutic target for the treatment of coronary artery disease, they said.


Geoffrey Kunz, M.D.



These endothelial progenitor cells (EPC) are produced in the bone marrow, and one of their roles is to repair damage to the lining of blood vessels. Duke cardiologists believe that one cause of coronary artery disease is an increasing inability over time of these EPCs to keep up with the damage caused to the arterial lining, or endothelium.

"In our study we found that patients with multi-vessel disease had many fewer EPCs, which supports our hypothesis that these cells play an important role in protecting blood vessels," said cardiologist Geoffrey Kunz, M.D., of the Duke Clinical Research Institute. "If you don’t have enough of the cells, the ongoing damage to the endothelium from traditional risk factors occurs faster than the body’s ability for repair."


Kunz presented the results of the Duke analysis March 9, 2004, at the annual scientific sessions of the American College of Cardiology.

In an article published last year in Circulation (July 29, 2003), Duke researchers reported discovering in mouse studies that a major outcome of aging is an unexpected failure of the bone marrow to produce EPCs needed to repair and rejuvenate arteries exposed to a genetically induced risk of high lipid levels. The researchers demonstrated that an age-related loss of these particular cells is critical to determining the onset and progression of atherosclerosis, which causes arteries to clog and become less elastic.

For the current study, the researchers measured the levels of EPCs in 122 patients undergoing diagnostic cardiac catheterization procedures at Duke and correlated those findings with the severity of coronary artery disease. Specifically, they determined how many of the coronary arteries showed signs of atherosclerosis.

The average age of the patient sample was 58, with 37 percent of them having multi-vessel disease, 29 percent having diabetes and 20 percent having had a recent heart attack.

The researchers removed EPCs from the blood samples and grew them in cell culture to determine how many of the cells would grow. The number of cells is measured as colony-forming units (CFU).

"We found that the patients with multi-vessel disease had significantly lower EPC counts than those without -- 13 CFU vs. 41.7 CFU," Kunz said. "Additionally, for every 10 CFU increase in EPC level, a patient’s likelihood for multi-vessel disease declined by 20 percent."

While the EPC levels did not vary significantly by age, gender or other risk factors, the researchers found that the levels were lower for diabetics (19 CFU vs. 36 CFU) and for patients who had suffered a recent heart attack (23 CFU vs. 34 CFU).

"These findings demonstrate a strong inverse relationship between circulating EPCs and coronary artery disease, independent of traditional disease risk factors," Kunz said.

The researchers said that it might ultimately be possible to forestall or even prevent development of atherosclerosis by injecting these cells into patients or by retraining the patient’s own stem cells to differentiate into progenitor cells capable of arterial repair.

While the direct clinical use of stem cells as a treatment might be many years off, the researchers said it is likely that strategies currently used to reduce the risks for heart disease -- such as lifestyle modifications and/or different medications -- preserve these rejuvenating cells for a longer period of time, which delays the onset of atherosclerosis.

"On the diagnostic front, it may be possible to take blood samples from a young person, and depending on measurements of the EPC levels, begin taking actions early that prevent the depletion of EPCs," Kunz said. "These cells might also be able to forestall the development of congestive heart failure in patients who have suffered a heart attack. In these ways, EPCs can play an important role in both primary and secondary prevention."

Other members of the Duke team were Grace Liang, Florim Cuculoski, David Gregg, M.D., Korkut Vata, Pascal Goldschmidt, M.D., Chumming Dong, M.D., Doris Taylor, Ph.D., and Eric Peterson, M.D.

Richard Merritt | dukemed news
Further information:
http://dukemednews.org/news/article.php?id=7451

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>